Patente
Hahnel und Müller: Automatisierbares portables System zur Extraktion von DNA aus schwierigen Proben. Utility Patent 20 2018 001 670 (IPC: C12N 15/10), eingetragen am 24.05.2018
Apfel J, Reischmann P, Müller O: Ein neuer Vektor und Protokolle zur Anreicherung und zur Analyse von Zellen mit aktiviertem Wnt-Signalweg Utility Patent (Ge
Veröffentlichungen
2019 - 2015
W. Hahnel, K. Schulte, M. Hafner, O. Müller, Extraction of DNA from Difficult Samples with an Automatable Portable System INTRODUCTION, IJPPR. 12 (2018) 238–250.
W. Hahnel, K. Schulte, O. Müller, Extraction of DNA from difficult samples with an automated portable system, in: Int. Conf. OnGenetics Mol. Res., Duba
1997-1990
Nimmrich I, Friedl W, Kruse R, Pietsch S, Hentsch S, Deuter R, Winde G, Müller O: Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Human Genetics 100: 345-349 (1997). https://doi.org/10.1007/s004390050514
Winde G,
1999-1998
Deka J, Herter P, Sprenger-Haußels M, Koosch S, Franz D, Müller KM, Kuhnen C, Hoffmann I, Müller O: The APC protein binds to A/T rich DNA sequences. Oncogene 18: 5654-5661 (1999). https://doi.org/10.1038/sj.onc.1202944
Herter P, Kuhnen C, Müller KM, Wittinghofer A, Müller O: Intracellular distribution of beta-catenin in colorectal
2001-2000
Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E, Laurent-Puig P, Olschwang S, Müller O, et al.: Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. British Journal of Cancer 85(5): 692-696 (2001). https:
2002
Tickenbrock L, Cramer J, Vetter I, Müller O: Structure of the aminoterminal nuclear export domain of the APC tumor suppressor protein. Annals of the New York Academy of Science 973: 109-111 (2002). http://dx.doi.org/10.1111/j.1749-6632.2002.tb04616.x
Brohm D, Philippe N, Metzger S, Bhargava A, Müller O, Lieb F, Waldmann H: Solid-Phase s
2004-2003
Karaguni IM, Gourzoulidou E, Carpintero M, Langerak A, Klein-Hitpaß L, Möröy T, Winde G, Waldmann H, Müller O: SMAF-1 inhibits the APC/b-catenin pathway and shows properties similar to these of the tumor suppressor protein APC. ChemBioChem 5(9): 1267-1270 (2004). https://doi.org/10.1002/cbic.200400078
Waldmann H, Karaguni IM, Carpi
2007-2006
Köster MP, Müller O, Pollerberg E: Adenomatous Polyposis Coli (APC) is differentially distributed in growth cones and modulates their local stability and steering. Journal of Neuroscience 27(46): 12590-12600 (2007). https://doi.org/10.1523/jneurosci.2250-07.2007
Fürstner A, Nevado C, Wasser M, Tremblay M, Chevrier C, Teply F, Aïssa
2009-2008
Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, Kuhnen C, Martin D, Müller O, Sievers S: ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 9, 447 (2009). https://doi.org/10.1186/1471-2407-9-447
Marelli MM, Moretti RM, Mai S, Müller O, van Groen
